Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies

Archbow’s SP Subject Matter Experts have created a list of forward-thinking questions that manufacturers should consider while meeting with their SP partners, whether they are launching a new product or looking to optimize an existing program. Here are some questions to consider:
-
- What core services does your pharmacy provide? Does it differ by product or disease state?
- How does your pharmacy determine how (or when) to move a service from core to enhanced (or vice versa)?
- Are there additional services your pharmacy offers that our program could benefit from?
- How does your pharmacy measure program success?
- What growth opportunities could you identify for our program?
- How could we spend more time during meetings/QBRs focused on the program’s future in addition to past metrics?
- What impacts has your pharmacy seen from the growth in medical benefit processing?
- How often does your pharmacy review contract fees for Fair Market Value (FMV)? Have you seen any changes in FMV over the past 3-5 years?
- What factors, outside of manufacturer contracts, impact your pharmacy’s economics?
- What sources can your pharmacy leverage outside of manufacturer contracts for financial relief?
Learn more about our pharmacy team and the differentiators that matter most to manufacturers, and contact us today for assistance with your strategic and tactical pharmacy needs.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
What’s Next for Pharmaceutical Distribution? HDA 2026 Distribution Management Conference Insights
HDA 2026 Distribution Management Conference Insights
The Next Generation of Patient Support
Healthcare is evolving rapidly, and patient support programs must keep pace.
CMS BFSF Rule: Critical Changes Every Pharma Company Must Address
Manufacturers must now submit ASP data with FMV documentation and BFSF fee certification for Medicare Part B drugs.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|


